<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25674854</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients.</ArticleTitle><Pagination><StartPage>3820</StartPage><EndPage>3830</EndPage><MedlinePgn>3820-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms16023820</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Diabetes mellitus is known to exacerbate bacterial infection, but its effect on the severity of viral infection has not been well studied. The severity of thrombocytopenia is an indicator of the severity of dengue virus infection. We investigated whether diabetes is associated with thrombocytopenia in dengue-infected patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied clinical characteristics of 644 patients with dengue infection at a university hospital during the epidemic on 1 June 2002 to 31 December 2002 in Taiwan. Platelet counts and biochemical data were compared between patients with and without diabetes. Potential risk factors associated with thrombocytopenia were explored using regression analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Dengue-infected patients with diabetes had lower platelet counts than patients without diabetes during the first three days (54.54&#xb1;51.69 vs. 86.58&#xb1;63.4 (p&#x2264;0.001), 43.98&#xb1;44.09 vs. 64.52&#xb1;45.06 (p=0.002), 43.86&#xb1;35.75 vs. 62.72&#xb1;51.2 (p=0.012)). Diabetes mellitus, death, dengue shock syndrome (DSS) and dengue hemorrhagic fever (DHF) and increased glutamic-pyruvate transaminase (GPT) levels were significantly associated with lower platelet counts during the first day of hospitalization for dengue fever with regression &#x3b2; of -13.981 (95% confidence interval (CI) -27.587, -0.374), -26.847 (95% CI -37.562, -16.132), and 0.054 (95% CI 0.015, 0.094) respectively. Older age, hypoalbuminemia, and hypertriglyceridemia were independently correlated with thrombocytopenia in dengue patients with or without diabetes with regression &#x3b2; of -2.947 (p=0.004), 2.801 (p=0.005), and -3.568 (p&#x2264;0.001), respectively. Diabetic patients with dengue had a higher rate of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) than non-diabetic patients. They also had lower blood albumin, were older, and higher triglyceride levels. Older age, hypoalbuminemia, and hypertriglyceridemia were independently correlated with thrombocytopenia in dengue patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dengue patients with diabetes tended to have more severe thrombocytopenia and were more likely to have DHF/DSS. Older age, hypoalbuminemia, and hypertriglyceridemia were independently associated with more severe thrombocytopenia in dengue patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chung-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Chin Pin Clinic, Kaohsiung 807, Taiwan. wecaredm223@yahoo.com.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mei-Yueh</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung 812, Taiwan. lovellelee@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Kun-Der</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. 890073@kmuh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Wei-Hao</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung 812, Taiwan. my345677@yahoo.com.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yaun-Jinn</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Lee's Clinic, Ping Tung 900, Taiwan. leesclinic@leesclinic.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Pi-Jung</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. pjhsiao@cc.kmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Shyi-Jang</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan. sjshin@kmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Lipid and Glycomedicine Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan. sjshin@kmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.6.1.2</RegistryNumber><NameOfSubstance UI="D000410">Alanine Transaminase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000410" MajorTopicYN="N">Alanine Transaminase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013921" MajorTopicYN="N">Thrombocytopenia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25674854</ArticleId><ArticleId IdType="pmc">PMC4346928</ArticleId><ArticleId IdType="doi">10.3390/ijms16023820</ArticleId><ArticleId IdType="pii">ijms16023820</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Joshi N., Caputo G.M., Weitekamp M.R., Karchmer A.W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 1999;341:1906&#x2013;1912. doi: 10.1056/NEJM199912163412507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199912163412507</ArticleId><ArticleId IdType="pubmed">10601511</ArticleId></ArticleIdList></Reference><Reference><Citation>Delamaire M., Maugendre D., Moreno M., Le Goff M.C., Allannic H., Genetet B. Impaired leucocyte functions in diabetic patients. Diabet. Med. 1997;14:29&#x2013;34. doi: 10.1002/(SICI)1096-9136(199701)14:1&lt;29::AID-DIA300&gt;3.0.CO;2-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9136(199701)14:1&lt;29::AID-DIA300&gt;3.0.CO;2-V</ArticleId><ArticleId IdType="pubmed">9017350</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexiewicz J.M., Kumar D., Smogorzewski M., Klin M., Massry S.G. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: Abnormalities in metabolism and function. Ann. Intern. Med. 1995;123:919&#x2013;924. doi: 10.7326/0003-4819-123-12-199512150-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-123-12-199512150-00004</ArticleId><ArticleId IdType="pubmed">7486486</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko E.J., Fihn S.D., Scholes D., Abraham L., Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am. J. Epidemiol. 2005;161:557&#x2013;564. doi: 10.1093/oxfordjournals.aje.a000181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a000181</ArticleId><ArticleId IdType="pubmed">15746472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoni A.G., Saydah S., Brancati F.L. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001;24:1044&#x2013;1049. doi: 10.2337/diacare.24.6.1044.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.24.6.1044</ArticleId><ArticleId IdType="pubmed">11375368</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510&#x2013;513. doi: 10.2337/diacare.26.2.510.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.26.2.510</ArticleId><ArticleId IdType="pubmed">12547890</ArticleId></ArticleIdList></Reference><Reference><Citation>Falguera M., Pifarre R., Martin A., Sheikh A., Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233&#x2013;3239. doi: 10.1378/chest.128.5.3233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.5.3233</ArticleId><ArticleId IdType="pubmed">16304267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu K., Cowie C.C., Harris M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971&#x2013;1993. Diabetes Care. 1998;21:1138&#x2013;1145. doi: 10.2337/diacare.21.7.1138.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.21.7.1138</ArticleId><ArticleId IdType="pubmed">9653609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangiorgio L., Attardo T., Gangemi R., Rubino C., Barone M., Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res. Clin. Pract. 2000;48:147&#x2013;151. doi: 10.1016/S0168-8227(99)00135-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8227(99)00135-7</ArticleId><ArticleId IdType="pubmed">10802152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo J.R., Guzm&#xe1;n M.G., Kouri G.P. Why dengue haemorrhagic fever in Cuba? Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) Trans. R. Soc. Trop. Med. Hyg. 1987;81:816&#x2013;820. doi: 10.1016/0035-9203(87)90041-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0035-9203(87)90041-1</ArticleId><ArticleId IdType="pubmed">3450004</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Kouri G. Dengue and dengue hemorrhagic fever in the Americas: Lessens and challenges. J. Clin. Virol. 2003;27:1&#x2013;13. doi: 10.1016/S1386-6532(03)00010-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(03)00010-6</ArticleId><ArticleId IdType="pubmed">12727523</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi A. Impact of dengue virus infection and its control. FEMS Immunol. Med. Microbiol. 1997;18:291&#x2013;300. doi: 10.1111/j.1574-695X.1997.tb01058.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.1997.tb01058.x</ArticleId><ArticleId IdType="pubmed">9348165</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Kouri G. Dengue: An uptake. Lancet Infect. Dis. 2000;13:261&#x2013;276.</Citation></Reference><Reference><Citation>Halstead S.B. Dengue: Hematologic aspects. Semin. Hematol. 1982;19:116&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">7041262</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson E.R., Bierman H.R. Dengue fever: Athrombocytopenic disease. JAMA. 1964;190:99&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">14184528</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Disease Control, Taiwan . Bulletin Statistics of Communicable Disease and Surveillance Report in Taiwan Area. Department of Health, The Executive Yuan; Taipei, Taiwan: 2004.</Citation></Reference><Reference><Citation>Carlos C.C., Oishi K., Cinco M.T., Mapua C.A., Inoue S., Cruz D.J., Pancho M.A., Tanig C.Z., Matias R.R., Morita K., et al. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am. J. Trop. Med. Hyg. 2005;73:435&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">16103617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Chen R.F., Liu J.W., Yu H.R., Kuo H.C., Yang K.D. Implications of dynamic changes among tumor necrosis factor-&#x3b1;, membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection. Am. J. Trop. Med. Hyg. 2007;77:297&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">17690402</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmannitya S. Clinical Manifestations of Dengue/Dengue Haemorrhagic Fever. Monograph on Dengue/Dengue Haemorrhagic Fever. World Health Organization, Regional Office for South-East Asi, Regional Publication; New Delhi, India: 1993. SEARO No. 22.</Citation></Reference><Reference><Citation>Pan American Health Organization . Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control. Scientific Publication; Northwest, Washington, DC, USA: 1994. No. 548.</Citation></Reference><Reference><Citation>Kaye W.A., Adri M.N., Soeldner J.S., Rabinowe S.L., Kaldany A., Kahn C.R., Bistrian B., Srikanta S., Ganda O.P., Eisenbarth G.S. Acquired defect in interleukin-2 production in patients with type I diabetes mellitus. N. Engl. J. Med. 1986;315:920&#x2013;924. doi: 10.1056/NEJM198610093151502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198610093151502</ArticleId><ArticleId IdType="pubmed">3531850</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerlings S.E., Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM) FEMS Immunol. Med. Microbiol. 1999;26:259&#x2013;265. doi: 10.1111/j.1574-695X.1999.tb01397.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.1999.tb01397.x</ArticleId><ArticleId IdType="pubmed">10575137</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsueh W.A., Lyon C.J., Quinones M.J. Insulin resistance and the endothelium. Am. J. Med. 2004;117:109&#x2013;117. doi: 10.1016/j.amjmed.2004.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2004.02.042</ArticleId><ArticleId IdType="pubmed">15234647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandona P., Alijada A., Chaudhuri A., Mohanty P. Endothelial dysfunction, inflammation and diabetes. Rev. Endocr. Metab. Dis. 2004;5:189&#x2013;197. doi: 10.1023/B:REMD.0000032407.88070.0a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:REMD.0000032407.88070.0a</ArticleId><ArticleId IdType="pubmed">15211090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Curiel I., Castaneda-Delgado J., Lopez-Lopez N., Araujo Z., Hernandez-Pando R., Gandara-Jasso B., Macias-Segura N., Enciso-Moreno A., Rivas-Santiago B. Differential expression of antimicrobial peptides inactive and latent tuberculosis and its relationship with diabetes mellitus. Hum. Immunol. 2011;72:656&#x2013;662. doi: 10.1016/j.humimm.2011.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2011.03.027</ArticleId><ArticleId IdType="pubmed">21539878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J., Salim A., Lee V.J., Hibberd M.L., Chia K.S., Leo Y.S., Lye D.C. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: A case control study. PLoS Negl. Trop. Dis. 2012;6:e1641. doi: 10.1371/journal.pntd.0001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001641</ArticleId><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S., Weissfeld L.A., Kapoor W.N. Prognosis and outcomes of patients with community-acquired pneumonia: A meta-analysis. JAMA. 1996;275:134&#x2013;141. doi: 10.1001/jama.1996.03530260048030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1996.03530260048030</ArticleId><ArticleId IdType="pubmed">8531309</ArticleId></ArticleIdList></Reference><Reference><Citation>Freire A.X., Bridges L., Umpierrez G.E., Kuhl D., Kitabchi A.E. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest. 2005;128:3109&#x2013;3116. doi: 10.1378/chest.128.5.3109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.5.3109</ArticleId><ArticleId IdType="pubmed">16304250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Dubois M.J., Navickis R.J., Wilkes M.M. Hypoalbuminemia in acute illness: Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann. Surg. 2003;237:319&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1514323</ArticleId><ArticleId IdType="pubmed">12616115</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Rodr&#xed;guez M., Medina-Cuadros M., G&#xf3;mez-Ortega A., Mart&#xed;nez-Gallego G., Mariscal-Ortiz M., Martinez-Gonzalez M.A., Sillero-Arenas M. Cholesterol and serum albumin levels as predictors of cross infection, death, and length of hospital stay. Arch. Surg. 2002;137:805&#x2013;812. doi: 10.1001/archsurg.137.7.805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.137.7.805</ArticleId><ArticleId IdType="pubmed">12093337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallin J.I., Kaye D., O'Leary W.M. Serum lipids in infection. N. Engl. J. Med. 1969;281:1081&#x2013;1086. doi: 10.1056/NEJM196911132812001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196911132812001</ArticleId><ArticleId IdType="pubmed">5824173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabana V.G., Siegel J.N., Sabesin S.M. Effect of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 1989;30:39&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">2493057</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold K.R., Hardardottir I., Memon R., Krul E.J.T., Moser A.H., Taylor J.M., Grunfeld C. The effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J. Lipid Res. 1993;34:2147&#x2013;2158.</Citation><ArticleIdList><ArticleId IdType="pubmed">8301233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly H., Francone O.L., Fielding C.J., Shigenaga J.K., Moser A.H., Grunfeld C., Feingold K.R. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res. 1995;36:1254&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pubmed">7666003</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold K.R., Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Investig. 1987;80:184&#x2013;190. doi: 10.1172/JCI113046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI113046</ArticleId><ArticleId IdType="pmc">PMC442217</ArticleId><ArticleId IdType="pubmed">3597772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>